|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-5-3
|
|
pubmed:abstractText |
Despite uncontroversial benefit from its thrombolytic activity, the documented neurotoxic effect of tissue plasminogen activator (tPA) raises an important issue: the current emergency stroke treatment might not be optimum if exogenous tPA can enter the brain and thus add to the deleterious effects of endogenous tPA within the cerebral parenchyma. Here, we aimed at determining whether vascular tPA crosses the blood-brain barrier (BBB) during cerebral ischemia, and if so, by which mechanism.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1065-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15817895-Animals,
pubmed-meshheading:15817895-Blood-Brain Barrier,
pubmed-meshheading:15817895-Brain Ischemia,
pubmed-meshheading:15817895-Cell Hypoxia,
pubmed-meshheading:15817895-Cytoplasmic Vesicles,
pubmed-meshheading:15817895-Endothelium, Vascular,
pubmed-meshheading:15817895-Glucose,
pubmed-meshheading:15817895-Infarction, Middle Cerebral Artery,
pubmed-meshheading:15817895-LDL-Receptor Related Proteins,
pubmed-meshheading:15817895-Male,
pubmed-meshheading:15817895-Mice,
pubmed-meshheading:15817895-Protein Transport,
pubmed-meshheading:15817895-Tissue Plasminogen Activator
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process.
|
|
pubmed:affiliation |
INSERM-Avenir, Centre Cyceron, Université de Caen, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
